Detalles de la búsqueda
1.
Total events and net clinical benefit of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: The COMPASS trial.
Am Heart J
; 258: 60-68, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646196
2.
The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease.
Circulation
; 142(1): 40-48, 2020 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32436455
3.
Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease: Insights From the COMPASS Trial.
Circulation
; 141(23): 1841-1854, 2020 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223318
4.
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
Circulation
; 140(7): 529-537, 2019 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31163978
5.
Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.
Circulation
; 140(18): 1451-1459, 2019 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31510769
6.
Stroke Outcomes in the COMPASS Trial.
Circulation
; 139(9): 1134-1145, 2019 02 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30667279
7.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28844192
8.
Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
Gastroenterology
; 157(2): 403-412.e5, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054846
9.
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.
Gastroenterology
; 157(3): 682-691.e2, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152740
10.
Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis.
Circulation
; 145(25): 1875-1877, 2022 06 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35728054
11.
Randomized trial of primary PCI with or without routine manual thrombectomy.
N Engl J Med
; 372(15): 1389-98, 2015 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-25853743
12.
Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial.
Age Ageing
; 45(1): 77-83, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590293
13.
Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES.
Eur Heart J
; 36(5): 281-7a, 2015 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25187524
14.
Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trial.
Eur Heart J
; 36(29): 1892-900, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994742
15.
Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial.
Eur Heart J
; 35(28): 1856-63, 2014 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-24569032
16.
Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
Stroke
; 45(7): 2127-30, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24916911
17.
Design and rationale of the TOTAL trial: a randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI.
Am Heart J
; 167(3): 315-321.e1, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24576514
18.
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy.
Eur Heart J
; 34(3): 170-6, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23018151
19.
The effects of apixaban on hospitalizations in patients with different types of atrial fibrillation: insights from the AVERROES trial.
Eur Heart J
; 34(35): 2752-9, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892201
20.
Bleeding during treatment with aspirin versus apixaban in patients with atrial fibrillation unsuitable for warfarin: the apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment (AVERROES) trial.
Stroke
; 43(12): 3291-7, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23033347